| Active substance |
Tamoxifen (Nolvadex) |
| Also known as |
TAM, tamoxifen citrate |
| Blood pressure |
Little to no effect on blood pressure |
| Chemical name |
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine |
| Concentration |
10 mg/tablet |
| Dosage (medical) |
20 mg daily |
| Dosage (sports) |
10-20 mg daily |
| Effects |
Reduces the effect of estrogen in the body, can stimulate ovulation |
| Formula |
C26H29NO |
| Half-life |
5 to 7 days |
| Hepatotoxicity |
Low, but rare cases of liver cancer and liver-related deaths have been reported |
| Lab Test |
Monitoring liver function tests is recommended |
| Main action |
Estrogen receptor antagonist |
| Side effects |
Hot flashes, vaginal discharge, menstrual irregularities, increased risk of endometrial cancer, cataracts, and thromboembolic events such as deep vein thrombosis and pulmonary embolism |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Selective Estrogen Receptor Modulator (SERM) |
| Trade name |
Nolvadex, Soltamox |
| Use in sports |
Used to counteract the side effects of anabolic steroids, specifically gynecomastia |
| Water Retention |
No |
| Manufacturer |
DEVA |
| Packing |
30 tablets |
